Related Experiment Video
Updated: Dec 17, 2025

A Method For Production of Recombinant mCD1d Protein in Insect Cells.
Published on: December 10, 2007
CD2 Immunobiology
Christian Binder1,2, Filip Cvetkovski2, Felix Sellberg1,2
1Department of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala University, Uppsala, Sweden.
Insights
The CD2 receptor on T cells is crucial for immune responses and memory T cell activation. Targeting the CD2/LFA3 pathway with biologics offers a promising strategy for treating T cell-related disorders.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Glycoprotein CD2 is a costimulatory receptor on T and NK cells, binding LFA3 on antigen-presenting cells.
- CD2 is vital for immunological synapse formation, organization, and intracellular signaling during T cell-APC conjugation.
- CD2 expression elevates on memory and activated T cells, significantly impacting memory T cell activation.
Purpose of the Study:
- To highlight the significance of the CD2/LFA3 costimulatory pathway in T cell activation.
- To explore the therapeutic potential of targeting CD2 for immune modulation.
- To emphasize CD2 as an attractive target for monoclonal antibody development.
Main Methods:
- Review of existing literature on CD2 function and its role in T cell activation.
- Analysis of studies involving anti-CD2 monoclonal antibodies and CD2-targeting biologics.
- Evaluation of clinical data on the safety and efficacy of CD2-targeting therapies.
Main Results:
- CD2 plays a key role in memory T cell activation, even with other costimulatory pathways present.
- Anti-CD2 antibodies demonstrate immunomodulatory effects in vitro.
- Clinical studies confirm the safety and efficacy of CD2-targeting biologics.
- The CD2/LFA3 pathway is identified as a potentially overlooked therapeutic target.
Conclusions:
- CD2 is a valuable target for monoclonal antibodies in treating conditions with aberrant T cell activation.
- Targeting CD2 allows for selective engagement of memory T cells.
- CD2-based therapies may promote immune regulation and offer a novel treatment avenue.
Abstract:
The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

